Xeris Pharmaceuticals (XERS)

[Rkrocks]

Let’s hope to break 3.00 soon

[price_and_volume]

Izzy Englander likes $XERS...

https://finance.yahoo.com/news/billionaire-israel-englander-pulls-trigger-133848525.html

[mess124]

Anybody know what this is G85CVR010 ? It-showed-in-my-TD-acct-after

Strongbridge vanished and XERS showed up.


Thank you

[Elgordo84]

Yes indeed

[alchemytrader]

Nice catch in the low 2.00s.

[Elgordo84]

Goodluck to all the Longs!

[$Money Bags$]

Ramping up for sure.

[Elgordo84]

I like what I see here!

Looks like a Trend reversal

Great with patience!

Let’s go $XERS

#EG84

[ahimsa27]

PDUFA New Years ?

[$Money Bags$]

They stalled the run when they first announced the merger, then silently listed their failed FDA trial in that q. They have more stuff in the pipeline and once the merger is done, maybe they can ramp revenue.

[ezyE]

Can we make it rain here?

[kzivann]

Premarket action .. nice news.


XERS

[tknuncle]

Where is the bottom to XERS? I grabbed a a couple hundred a few days ago and it just keeps dropping more an more. Even after the good news today and yesterday. I was hoping maybe someone had an opinion they would like to share. Also does anyone know the real OS or Float? When I look at the OTC website I see it hasn't been updated since March 22nd.

https://www.otcmarkets.com/stock/SLS/security

Thanks for any feed back. Much appreciated

[$Money Bags$]

Item 5.

Ownership of 5 Percent or Less of a Class. If this statement is being
filed to report the fact that as of the date hereof the reporting person
has ceased to be the beneficial owner of more than 5 percent of the
class of securities, check the following [ X ].

[$Money Bags$]

Blackrock sold 2.1m shares into it since their last filing in May until today. If they are done suppressing it now, maybe it can finally head north to where it belongs.

[Modlich]

Company on verge of bullish long run consolidated after bull flag bo last 2 days, imo anything over 5.2
and this could easily hit 7.8, breaks that or news stock can easily reach double digits.

[$Money Bags$]

Nom nom nom bring the gains.

[$Money Bags$]

They are acquiring another company, which pushed the profitability timeline back and it reflected in that. That said, it'll cross the threshold a little harder. Some nice gains whether flipping or bottom feeding long.

[harr449]

Recent announcement of deal caused PT to go from $14 to $9.

[$Money Bags$]

You guys enjoying the start of this nice run?

[$Money Bags$]

Delicious.

[$Money Bags$]

Once these conversions clear the landscape will probably change quick. I would think we are close too, but...

[I Dump]

Falcon stocks has them as a buy this week. Holding off yet. Maybe bottom is near.

[$Money Bags$]

So many conversions knocking the floor out of this thing. One day, pow, right in the kisser.

[$Money Bags$]

Conversions on this are still brutal. Float is low, one day she breaks the chains.

[$Money Bags$]

Must be looming conversions. Company events looking good.

[$Money Bags$]

Must be looming conversions. Company events looking good.

[$Money Bags$]

Good news out after hours. $$$

[$Money Bags$]

Wonder if the convertible debt is done now. Looking like it may be. Gonna get interesting when it dries up.

[$Money Bags$]

Made some big buys over the last few days and all of them bared fruit today. Here's to the green mile.

[mte1955]

My thoughts exactly. Hopefully the dance continues for this and many other stocks.

[$Money Bags$]

Bought a bunch of 4.38's today. Flip forever and ever here. I still think it'll head north eventually.

[$Money Bags$]

Almost all of the convertible debt is extinguished. At current rate, probably in the next 10 days it will be gone at an average of $3ish a share, hence this hard drop. They have growing revenue, could be building the perfect storm. They have plenty of cash on hand. Started buying at $4.50 and have buys down to $3. Any takes on it?

[Termite7]

Good chart!!!

[trustbutverifyit]

Amazed this board is so quiet on this ticker. It has been hopping on ST for a month now. $10 coming soon.

[Cpops]

The secret is out!

[TFMG]

$XERS | #Xeris Pharma On Breakout Watch



Alert set for a break above the 200ma and $5.00 level.
Highly speculative with high Risk| Reward .
Company profile
Xeris Pharmaceuticals , Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.


PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.

[@LaughinPaulRyan]

... GTFOH ... $XERS

EPIC LOSSES
NO CORONA AND LIME
BEER MONEY TRAPPED FOREVER

$XERS went public at 15 only 2 years ago. While 7 looks good to someone buying at 3, there's a lot of investors who'd be taking a loss at 7. The ultra bull case is $XERS gets up to the mid teens organically and then gets a buyout for a big premium in the mid 20s

#ROFLMFAO #EatLOSSES

[ClayTrader]

* * $XERS Video Chart 08-13-2020 * *

Link to Video - click here to watch the technical chart video

[AW104]

Loading here. Great day today. Looking good for a pop. Patience here. $4-5 not too far away...

[Gabester]

Gm $Xers Loading up some more.

[logsplitter]

I am loaded to the gills

[logsplitter]

We gonna pound the shorts

[Gabester]

Very soon I see $4-$6

[Gabester]

Yes it will

[Jellyfish]

Will be in next week! Happy 4th.

[logsplitter]

She gonna fly soon

[Golden Cross]

Do you think we are ready here crude? $XERS

[crudeoil24]

On June 30, 2020, Xeris Pharmaceuticals, Inc. (the “Company”) completed its previously announced underwritten public offering (the “Notes Offering”) of $75.0 million aggregate principal amount of the Company’s 5.00% Convertible Senior Notes due 2025 (the “Notes”). As previously announced, the Company granted the underwriters of the Notes Offering a 30-day option to purchase up to an additional $11.25 million aggregate principal amount of Notes, solely to cover over-allotments. As of the date of this Current Report on Form 8-K, the underwriters of the Notes Offering have not exercised their option to purchase additional Notes.

[Golden Cross]

Xeris Pharmaceuticals (NASDAQ:XERS) Cut to "Hold" at Zacks Investment Research
6/23/20, 03:32 AM - Ticker Report
Summary
Zacks Investment Research lowered shares of Xeris Pharmaceuticals (NASDAQ:XERS) from a buy rating to a hold rating in a research report released on Saturday morning, Zacks.com reports. Zacks Investment Research currently has $5.75 target price on the stock. According to Zacks, Xeris ...